Published in

Terapevticheskii arkhiv, 4(93), p. 487-496, 2021

DOI: 10.26442/00403660.2021.04.200689

Links

Tools

Export citation

Search in Google Scholar

AL-amyloidosis with cardiac involvement. Diagnostic capabilities of non-invasive methods

Journal article published in 2021 by Alexandra Y.-A. Gudkova ORCID, Sergei V. Lapekin ORCID, Tinatin G. Bezhanishvili ORCID, Maria A. Trukshina ORCID, Victoria G. Davydova ORCID, Aleksandr N. Krutikov ORCID, Aleksandr N. Kulikov ORCID, Anna A. Streltsova, Sofiia E. Andreeva ORCID, Roman V. Grozov ORCID, Anzhelika A. Poliakova ORCID, Anna A. Kostareva ORCID, Galina N. Salogub ORCID, Evgenii V. Shlyakhto ORCID
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Question mark in circle
Preprint: policy unknown
Upload
Question mark in circle
Postprint: policy unknown
Upload
Question mark in circle
Published version: policy unknown
Upload

Abstract

There are presented the literature data and a description of the clinical course of the disease in isolated/predominant cardiac amyloidosis. Amyloid cardiomyopathy is the most common phenocopy of hypertrophic cardiomyopathy. The modern possibilities of non-invasive diagnostics using osteoscintigraphy for the differential diagnosis between amyloid cardiomyopathy caused by AL- and transthyretin amyloidosis are described in detail.